The results showed that ACSM3 was markedly low expressed in ovarian cancer tissues than normal tissues (Figure 1A) Survival analysis revealed that the low expression level of ACSM3 was related with poorer overall survival than high mRNA expression of ACSM3 in 424 ovarian cancer patients, suggesting the prognostic significance of ACSM3. (Figure 1B). Here, ACSM3 is linked to ovarian cancer.